title: Altered cholesterol and fatty acid metabolism in Huntington disease.
abstract: Huntington disease is an autosomal dominant neurodegenerative disorder characterized by behavioral abnormalities, cognitive decline, and involuntary movements that lead to a progressive decline in functional capacity, independence, and ultimately death. The pathophysiology of Huntington disease is linked to an expanded trinucleotide repeat of cytosine-adenine-guanine (CAG) in the IT-15 gene on chromosome 4. There is no disease-modifying treatment for Huntington disease, and novel pathophysiological insights and therapeutic strategies are needed. Lipids are vital to the health of the central nervous system, and research in animals and humans has revealed that cholesterol metabolism is disrupted in Huntington disease. This lipid dysregulation has been linked to specific actions of the mutant huntingtin on sterol regulatory element binding proteins. This results in lower cholesterol levels in affected areas of the brain with evidence that this depletion is pathologic. Huntington disease is also associated with a pattern of insulin resistance characterized by a catabolic state resulting in weight loss and a lower body mass index than individuals without Huntington disease. Insulin resistance appears to act as a metabolic stressor attending disease progression. The fish-derived omega-3 fatty acids, eicosapentaenoic acid and docosahexaenoic acid, have been examined in clinical trials of Huntington disease patients. Drugs that combat the dysregulated lipid milieu in Huntington disease may help treat this perplexing and catastrophic genetic disease.
authors.affiliation: Division of Epidemiology, Department of Community and Preventive Medicine and Preventive Cardiology Unit, Box 644, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Rochester, NY 14620, USA. robert_block@urmc.rochester.edu
authors.forename: Robert C
authors.initials: RC
authors.lastname: Block
authors.forename: E Ray
authors.initials: ER
authors.lastname: Dorsey
authors.forename: Christopher A
authors.initials: CA
authors.lastname: Beck
authors.forename: J Thomas
authors.initials: JT
authors.lastname: Brenna
authors.forename: Ira
authors.initials: I
authors.lastname: Shoulson
mesh_terms: D002490:Central Nervous System / Q000378:metabolism; D002784:Cholesterol / Q000378:metabolism*; D005227:Fatty Acids / Q000378:metabolism*; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage / Q000378:metabolism; D006801:Humans; D000071058:Huntingtin Protein; D006816:Huntington Disease / Q000178:diet therapy / Q000235:genetics / Q000378:metabolism*; D007333:Insulin Resistance; D050356:Lipid Metabolism; D050505:Mutant Proteins / Q000378:metabolism; D009419:Nerve Tissue Proteins / Q000378:metabolism; D009687:Nuclear Proteins / Q000378:metabolism
chemical_list: D005227:Fatty Acids; D015525:Fatty Acids, Omega-3; C086055:HTT protein, human; D000071058:Huntingtin Protein; D050505:Mutant Proteins; D009419:Nerve Tissue Proteins; D009687:Nuclear Proteins; D002784:Cholesterol
references.citation: Dev Neurosci. 1997;19(4):312-20
references.pmid: 9215876
references.citation: J Nutr. 1987 Oct;117(10):1663-70
references.pmid: 2822876
references.citation: FASEB J. 2009 Jun;23(6):1946-57
references.pmid: 19211925
references.citation: Curr Opin Clin Nutr Metab Care. 2008 Mar;11(2):100-5
references.pmid: 18301083
references.citation: Clin Sci (Lond). 2009 Jan;116(1):1-16
references.pmid: 19037880
references.citation: Exp Brain Res. 2005 Oct;166(2):220-9
references.pmid: 16034568
references.citation: Diabetes. 2000 Jun;49(6):975-80
references.pmid: 10866050
references.citation: J Lipid Res. 2000 Oct;41(10):1629-39
references.pmid: 11013305
references.citation: Circulation. 2002 Nov 19;106(21):2747-57
references.pmid: 12438303
references.citation: Arch Neurol. 2008 Dec;65(12):1582-9
references.pmid: 19064745
references.citation: BMC Med. 2005 Jun 23;3:11
references.pmid: 15975147
references.citation: Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9799-804
references.pmid: 8790411
references.citation: Hum Mol Genet. 2002 Aug 15;11(17):1953-65
references.pmid: 12165557
references.citation: Prostaglandins Leukot Essent Fatty Acids. 2009 Feb-Mar;80(2-3):157-63
references.pmid: 19237271
references.citation: J Biol Chem. 2008 Sep 12;283(37):25628-25637
references.pmid: 18640979
references.citation: Neurosci Lett. 1998 Jan 16;240(3):177-81
references.pmid: 9502233
references.citation: J Neurosci. 2005 Oct 26;25(43):9932-9
references.pmid: 16251441
references.citation: Arch Neurol. 2008 Apr;65(4):476-80
references.pmid: 18413469
references.citation: Hum Mol Genet. 2002 Nov 1;11(23):2815-28
references.pmid: 12393793
references.citation: Am J Cardiol. 2006 Aug 21;98(4A):27i-33i
references.pmid: 16919514
references.citation: Nat Genet. 1994 Aug;7(4):525-30
references.pmid: 7951324
references.citation: Ann Neurol. 1977 May;1(5):423-5
references.pmid: 152597
references.citation: Am J Clin Nutr. 1997 May;65(5 Suppl):1645S-1654S
references.pmid: 9129504
references.citation: Brain. 2006 Apr;129(Pt 4):877-86
references.pmid: 16464959
references.citation: Brain Res Bull. 2007 Apr 30;72(2-3):159-64
references.pmid: 17352940
references.citation: Neurology. 1988 May;38(5):769-72
references.pmid: 2966305
references.citation: Mol Genet Metab. 2008 Mar;93(3):341-6
references.pmid: 18006350
references.citation: Prog Neurobiol. 2006 Nov;80(4):165-76
references.pmid: 17067733
references.citation: Biol Psychiatry. 1998 Aug 15;44(4):235-42
references.pmid: 9715354
references.citation: Neurosci Lett. 2007 Jan 10;411(2):98-103
references.pmid: 17110029
references.citation: Nat Neurosci. 2006 Jun;9(6):824-31
references.pmid: 16699508
references.citation: Nat Neurosci. 2005 Apr;8(4):468-75
references.pmid: 15793579
references.citation: Prostaglandins Leukot Essent Fatty Acids. 2007 Nov-Dec;77(5-6):319-26
references.pmid: 18060753
references.citation: Circulation. 2009 Feb 3;119(4):628-47
references.pmid: 19139390
references.citation: Science. 2002 May 10;296(5570):1118-20
references.pmid: 12004130
references.citation: Nat Rev Immunol. 2008 May;8(5):349-61
references.pmid: 18437155
references.citation: Cell. 1993 Mar 26;72(6):971-83
references.pmid: 8458085
references.citation: J Lipid Res. 2004 Aug;45(8):1437-45
references.pmid: 15175358
references.citation: Am J Clin Nutr. 2005 Aug;82(2):281-95
references.pmid: 16087970
references.citation: Biochim Biophys Acta. 2003 Feb 20;1631(1):77-84
references.pmid: 12573452
references.citation: J Lipid Res. 2003 Oct;44(10):1984-91
references.pmid: 12837849
references.citation: Neurology. 2006 Feb 14;66(3):366-72
references.pmid: 16476934
references.citation: Carcinogenesis. 2003 May;24(5):919-25
references.pmid: 12771037
references.citation: Exp Neurol. 2005 Dec;196(2):266-72
references.pmid: 16129433
references.citation: J Lipid Res. 1997 Sep;38(9):1851-8
references.pmid: 9323594
references.citation: Clin Genet. 1985 Jan;27(1):62-7
references.pmid: 3156696